Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Real-world HIV RNA and Antigen/Antibody Testing Among People Who Use Long-acting Injectable Preexposure Prophylaxis

1 Apr 2025

Abstract excerpt

BACKGROUND: People who use long-acting injectable cabotegravir (CAB-LA) for preexposure prophylaxis (PrEP) can have ambiguous human immunodeficiency virus (HIV) test results if HIV is acquired during its use. The 2021 Centers for Disease Control and Prevention PrEP guidelines recommend both HIV antigen/antibody (Ag/Ab) and RNA testing at CAB-LA initiation and follow-up. METHODS: We conducted a cohort study using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS Research and Interventions
Share to HIV-related health complications and treatments
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40176250
DOI: 10.1093/cid/ciaf173

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real-world HIV RNA and Antigen/Antibody Testing Among People Who Use Long-acting Injectable Preexposure ProphylaxisPMID 40176250Read ↗

Should antigen-antibody rapid diagnostic tests be used to detect acute HIV infection? A systematic review and meta-analysis of diagnostic performanceSemantic proximity Read ↗

Brief Report: Incidence of HIV in a Nationwide Cohort Receiving Pre-exposure Prophylaxis for HIV Prevention.Semantic proximity Read ↗

HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention.Semantic proximity Read ↗

First Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine CareSemantic proximity Read ↗

Should WHO-prequalified antigen-antibody fourth-generation rapid diagnostic tests be used to detect acute HIV infection? A systematic review and meta-analysis of diagnostic performanceSemantic proximity Read ↗

Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirineSemantic proximity Read ↗

Pre-exposure Prophylaxis Use History in People With Antiretroviral Resistance at HIV Diagnosis: Findings From New York City HIV Surveillance and Partner Services, 2015-2022.Semantic proximity Read ↗

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.Semantic proximity Read ↗

Association Between ART Initiation Timing and Treatment Outcomes in Older People Living With HIV: A Longitudinal Study from Baise, ChinaSemantic proximity Read ↗

HIV-1 genetic diversity to estimate time of infection and infer adherence to preexposure prophylaxis.Semantic proximity Read ↗

HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.Semantic proximity Read ↗

False Positivity in Anti-HIV Tests: Causes and Determination of a Reliable Cut-Off ValueSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.